Manipulating microRNAs for the Treatment of Malignant Pleural Mesothelioma: Past, Present and Future.

Front Oncol · 2020 · PMC7020748 · PMID 32117755

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

likely to be significantno p-value reported

Taken together, mutations in these three signature pathways are likely to be significant contributors to the global miRNA downregulation found in MPM.

also in 1,824 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.